# CISATRACURIUM BESYLATE
> **ANDA203236** · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2018-03-30
## Drug
- **FDA Application Number:** ANDA203236
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** HOSPIRA
- **Manufacturer:** Hospira, Inc.
- **First approval:** 2018-03-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203236)
---
*AI Analytics · CC0 1.0*